Right at Home Ventures Research
Investment Thesis
Right at Home Ventures, also referred to in some sources as Right at Home Corporate Ventures, is a corporate venture fund launched by Right at Home Corporate to back companies enabling the future of aging at home. The strongest primary source is the firm's own website, https://rightathomeventures.com/, which says the fund is actively looking to invest in companies that help seniors age at home. The site connects the investment thesis directly to Right at Home's operating footprint: more than 25 years in home care and a network of 600+ franchise locations. The fund's stated belief is that the future of senior care will depend on technology, services, and products that let older adults live comfortably and independently in their own homes.
The thesis is narrow and strategic rather than broadly healthcare-oriented. Right at Home Ventures looks for AgeTech solutions and products that improve operations for home-care franchisees. The website specifically names AgeTech, B2B SaaS, and operational software as example models that can scale across the national franchise network. AgeTech Connect, at https://www.agetechconnect.com/capital-and-other-resources, independently lists Right at Home Ventures as a seed-stage corporate venture fund backing U.S.-based startups focused on enabling aging at home. The Next50 Aging Investing Roadmap, published at https://next50foundation.org/wp-content/uploads/2026/04/Next50-AgingInvestingRoadmap-FINAL-PRINT.pdf, includes Right at Home Corporate Ventures in its appendix of funds focused on aging and describes it as investing in early-stage companies with innovative solutions that enhance aging at home.
Stage Focus
Right at Home Ventures is publicly positioned as seed-stage. The firm website describes it as a $5MM seed-stage corporate venture fund, and AgeTech Connect repeats the same seed-stage framing. Bailey Paxton's public LinkedIn post at https://www.linkedin.com/posts/bailey-p_agetech-medtech-venturecaptial-activity-7373814815443775488-2dq9 says Right at Home Ventures is investing in Seed to Series A startups, so the most defensible stage range is Seed as the core entry point with selective Series A interest. There is no source-backed evidence of pre-seed, growth, private equity, or public-market activity.
Check Size
The only source-backed capital figure found is the fund size: the website states that Right at Home Corporate launched a $5MM seed-stage corporate venture fund. No public source found during this research gives a per-company check size, reserve policy, target ownership, or follow-on amount. The payload therefore omits check-size minimum and maximum rather than guessing. Given the fund size and corporate strategic model, founders should verify check size directly before treating Right at Home Ventures as a round lead.
Lead Tendency
Lead tendency is unknown. The firm describes itself as providing capital, healthcare expertise, access to franchise partners, and industry mentors, but it does not state whether it leads rounds, co-leads, or participates alongside other investors. The available public language emphasizes strategic support and access to Right at Home's network more than ownership targets or lead-investor behavior. A conservative founder-facing interpretation is that Right at Home Ventures may be especially valuable as a strategic investor for distribution, pilots, and market insight, while lead capacity should be confirmed case by case.
Recent Activity
Recent public activity shows the fund is actively building its AgeTech presence. The website remains live and invites founders to submit company information or contact [email protected]. The AgeTech Podcast episode “Inside Right at Home's New AgeTech Fund,” published November 21, 2025 at https://creators.spotify.com/pod/profile/thegerontechnologist/episodes/Inside-Right-at-Homes-New-AgeTech-Fund-e3b97u4, features Bailey Paxton discussing what founders need to know if they want to sell into home care or raise from Right at Home's new venture arm. The episode description emphasizes real operating pain points, preferred-vendor selection, business models home-care owners accept, ROI needed to move beyond pilots, caregiver retention solutions, and in-home monitoring. The Indiana Life Sciences Association event page for the New York Venture Summit, https://inlifesciences.org/2025/05/16/new-york-venture-summit/, lists Bailey Paxton, Director of Venture Investment at Right at Home Ventures, among featured VCs for the September 9-10, 2025 event. The April 2026 Next50 roadmap also lists Right at Home Corporate Ventures among funds focused on aging.
Portfolio Highlights
Named portfolio companies were not found in public sources reviewed. The firm website says startups in its portfolio gain access to healthcare professionals, franchise partners, and mentors, so a portfolio exists or is intended, but the public site does not list company names. Because no named investments could be source-backed, this research should treat the portfolio as undisclosed. The required structured portfolio field uses the existing F4 placeholder “Undisclosed Right at Home Ventures portfolio company” to avoid fabricating a specific company. No exits were found.
Team
Bailey Paxton is the clearly source-backed venture team member. The New York Venture Summit page lists him as Director of Venture Investment at Right at Home Ventures. His public LinkedIn activity identifies him as the person inviting AgeTech founders to talk with Right at Home Ventures, and search-result snippets for his LinkedIn profile describe him as Director of Venture Investment & In-Home Care Technology for Right at Home Corporate. Crunchbase snippets describe him as Director of In Home Care Technology & Innovation at Right at Home and note prior founder experience at AgileCare Solutions. The fund's website provides a general contact point at [email protected].
Decision Process
The public process starts with founder inbound through the website's “Submit Company Information” call to action. No source describes the investment committee, diligence sequence, approval structure, or decision timeline. The most likely diligence emphasis, based on the website and podcast description, is fit with the Right at Home franchise network, home-care operational ROI, acceptance by home-care owners, and ability to scale across a distributed national network. Those inferences should be treated as operationally grounded but not confirmed procedural details.
Founder Preferences
Right at Home Ventures says it looks for innovative startups, visionary founders, and scalable solutions. The website states that preferred founders are mission-driven entrepreneurs with proven track records who are passionate about improving quality of life for older adults. Strong fits likely include founders building in-home monitoring, caregiver retention, care operations, senior independence, franchise workflow software, care coordination, or other tools that can produce measurable ROI for home-care operators. Poor fits likely include companies outside aging-at-home or home-care operations, non-U.S. startups, products that cannot scale across a franchise network, or pilots without a credible path to operational adoption.
Geographic Focus
The firm is U.S.-focused. The website says it is dedicated to U.S.-based startups, and AgeTech Connect uses the same geographic framing. Right at Home's corporate base is associated with Omaha, Nebraska, while the value proposition is national because of the 600+ franchise-location network across the United States. No public evidence was found for international investing.